现在是重新考虑心脏性休克的时候了:休克对生存的框架文件
Marie Buckel1, Alastair G Proudfoot2,3
1Pan-London Intensive Care Medicine Training Programme, London, UK.
概括
改善心脏性休克护理需要通过教育和专注的心脏超声波进行早期识别. 建立专业的休克中心和多学科团队对于更好的患者结果至关重要.
科学领域:
- 心血管医学 心血管医学
- 临界护理医学 临界护理医学
背景情况:
- 心脏性休克是一种危及生命的疾病,尽管医学进步,死亡率仍然很高.
- 目前对心脏性休克的治疗在临床实践和医疗保健系统中面临着重大挑战.
研究的目的:
- 总结一下"震惊到生存"的文件,详细介绍了目前和未来国家心脏性休克护理的理想状态.
- 突出改善心脏性休克患者结果的关键领域.
主要方法:
- 审查和总结"震惊到生存"国家护理文件.
- 重点是早期识别低输液并通过聚焦心脏超声波确认心脏病因.
主要成果:
- 早期识别心脏性休克需要加强教育和培训.
- 访问专门的"冲击中心"和专家多学科团队对于管理各种原因至关重要.
- 对于强大的数据集来指导最佳实践和研究,存在着至关重要的需求.
结论:
- 优化心脏性休克护理需要系统的方法,包括早期检测,专业中心和专家团队.
- 开发全面的数据集对于推进基于证据的实践和心脏性休克管理方面的创新至关重要.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
22
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
22
Cardiopulmonary Resuscitation I: Adult
20
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
20
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Cardiopulmonary Resuscitation III: AED Use
38
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
38
Heart Failure V: Medical Management
14
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
14


